198 related articles for article (PubMed ID: 21608079)
1. p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells.
Paolella BR; Havrda MC; Mantani A; Wray CM; Zhang Z; Israel MA
Stem Cells; 2011 Jul; 29(7):1090-101. PubMed ID: 21608079
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation Regulates Id2 Degradation and Mediates the Proliferation of Neural Precursor Cells.
Sullivan JM; Havrda MC; Kettenbach AN; Paolella BR; Zhang Z; Gerber SA; Israel MA
Stem Cells; 2016 May; 34(5):1321-31. PubMed ID: 26756672
[TBL] [Abstract][Full Text] [Related]
3. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
4. Elevated Id2 expression results in precocious neural stem cell depletion and abnormal brain development.
Park HJ; Hong M; Bronson RT; Israel MA; Frankel WN; Yun K
Stem Cells; 2013 May; 31(5):1010-21. PubMed ID: 23390122
[TBL] [Abstract][Full Text] [Related]
5. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.
Coma S; Amin DN; Shimizu A; Lasorella A; Iavarone A; Klagsbrun M
Cancer Res; 2010 May; 70(9):3823-32. PubMed ID: 20388805
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Id2 increases chemosensitivity of glioma.
Zhao Z; He H; Wang C; Tao B; Zhou H; Dong Y; Xiang J; Wang L; Luo C; Lu Y; Yu X
Tumour Biol; 2015 Jun; 36(6):4189-96. PubMed ID: 25773386
[TBL] [Abstract][Full Text] [Related]
7. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
[TBL] [Abstract][Full Text] [Related]
8. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
Yan W; Chen X
Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
[TBL] [Abstract][Full Text] [Related]
9. Large scale RNAi screen reveals that the inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiation.
Wu N; Castel D; Debily MA; Vigano MA; Alibert O; Mantovani R; Iljin K; Romeo PH; Gidrol X
J Biol Chem; 2011 Jun; 286(23):20870-9. PubMed ID: 21478550
[TBL] [Abstract][Full Text] [Related]
10. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.
Yan W; Liu G; Scoumanne A; Chen X
Cancer Res; 2008 Aug; 68(16):6789-96. PubMed ID: 18701504
[TBL] [Abstract][Full Text] [Related]
11. The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells.
Dong HJ; Jang GB; Lee HY; Park SR; Kim JY; Nam JS; Hong IS
Sci Rep; 2016 Mar; 6():22966. PubMed ID: 26965643
[TBL] [Abstract][Full Text] [Related]
12. Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation.
Talaverón R; Matarredona ER; Herrera A; Medina JM; Tabernero A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238452
[TBL] [Abstract][Full Text] [Related]
13. Activated
Qin Z; Liang W; Zhang Z; Li P; Wang T; Chen Q; Guo B; Zhong Y; Kang H; Wang L
Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37326110
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
[TBL] [Abstract][Full Text] [Related]
15. ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness.
Liu Y; Pandey PR; Sharma S; Xing F; Wu K; Chittiboyina A; Wu SY; Tyagi A; Watabe K
Breast Cancer Res Treat; 2019 May; 175(1):77-90. PubMed ID: 30725231
[TBL] [Abstract][Full Text] [Related]
16. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
17. Generation of neuronal progenitor cells in response to tumors in the human brain.
Macas J; Ku MC; Nern C; Xu Y; Bühler H; Remke M; Synowitz M; Franz K; Seifert V; Plate KH; Kettenmann H; Glass R; Momma S
Stem Cells; 2014 Jan; 32(1):244-57. PubMed ID: 24170295
[TBL] [Abstract][Full Text] [Related]
18. miR-106b regulates the proliferation and differentiation of neural stem/progenitor cells through Tp53inp1-Tp53-Cdkn1a axis.
Xia X; Lu H; Li C; Huang Y; Wang Y; Yang X; Zheng JC
Stem Cell Res Ther; 2019 Sep; 10(1):282. PubMed ID: 31547867
[TBL] [Abstract][Full Text] [Related]
19. Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
Meng Y; Gu C; Wu Z; Zhao Y; Si Y; Fu X; Han W
BMC Cancer; 2009 Mar; 9():75. PubMed ID: 19257909
[TBL] [Abstract][Full Text] [Related]
20. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
